Register Now!
All content on iDOC is free & registration
is simple!
Evaluating Clinical Use of Long-Acting GLP-1 Therapy in Type 2 Diabetes Treatment Regimens
Patrick J. Boyle, MD
This program has been approved for up to 1.50 credits.
Long-Acting GLP-1 Receptor Agonist Therapy: Improving Efficacy, Adherence, and Weight in T2DM
Ralph A. DeFronzo, MD, Chair; John B. Buse, MD, PhD; David D`Alessio, MD
This program has been approved for up to 1.50 credits.
Shared Decision Making for Clinical Success in the Obese Person with Type 2 Diabetes
Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD
Clinical Shared Decision Making with the Obese Person with Type 2 Diabetes and A BMI >35
Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD
Personalized Health Risk Management and Therapeutic Decision-Making in Type 2 Diabetes
Patrick J. Boyle, MD and Frank Lavernia, MD
Successfully Implementing Personalized Decision Making in Type 2 Diabetes
Janice L. Koshinsky, RN, MS, CDE and Frank Lavernia, MD
Practical Opinions: Personalizing Patient Treatment Goals and Care Management in a Recently Diagnosed Type 2 Diabetes Patient
Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD
Practical Opinions-Personalizing Patient Treatment Goals and Care Management in an Older Patient with Established Type 2 Diabetes
Patrick J. Boyle, MD, Janice L. Koshinsky, RN, MS, CDE, Frank Lavernia, MD
Effective Use of InsulinThrough the Progression of Type 2 Diabetes - Q & A
Silvio Inzucchi, MD and Geralyn Spollett, MSN, ANP, CDE
This program has been approved for up to 1.50 credits.
Effective Use of Insulin Through the Progression of Type 2 Diabetes
Silvio Inzucchi, MD and Geralyn Spollett, MSN, ANP, CDE
This program has been approved for up to 1.50 credits.